Halozyme Therapeutics, Inc. trades by members of Congress

Purchases and sales of Halozyme Therapeutics, Inc. shares that members of the House have disclosed since January 3, 2015, with the value range each one reported and a link to the original filing.

Purchases, last 12 months 1 trade Reported value $1,001–$15,000 (sum of the ranges filed)

Sales, last 12 months 1 trade Reported value $1,001–$15,000 (sum of the ranges filed)

Members trading, last 12 months 1 10 purchases and sales since January 3, 2015

Halozyme Therapeutics, Inc. trades disclosed by members of Congress
				Report
Gilbert Ray Cisneros, Jr. House · D-CA 31	Sale (partial)$1,001 - $15,000	Oct 12, 2026	Sep 29, 2026	Filing for HALO on Sep 29, 2026
Gilbert Ray Cisneros, Jr. House · D-CA 31	Purchase$1,001 - $15,000	Apr 7, 2026	Mar 9, 2026	Filing for HALO on Mar 9, 2026
Gilbert Ray Cisneros, Jr. House · D-CA 31	Sale (partial)$1,001 - $15,000	Apr 7, 2025	Mar 24, 2025	Filing for HALO on Mar 24, 2025
Josh Gottheimer House · D-NJ 5	Sale (partial)$1,001 - $15,000 · Joint	Oct 3, 2024	Sep 9, 2024	Filing for HALO on Sep 9, 2024
Daniel S. Goldman House · D-NY 10	Sale (full)$15,001 - $50,000	Aug 13, 2023	Jul 12, 2023	Filing for HALO on Jul 12, 2023
Josh Gottheimer House · D-NJ 5	Sale (partial)$1,001 - $15,000 · Joint	Jan 13, 2023	Dec 6, 2022	Filing for HALO on Dec 6, 2022
Josh Gottheimer House · D-NJ 5	Sale (partial)$1,001 - $15,000 · Joint	Sep 16, 2022	Aug 5, 2022	Filing for HALO on Aug 5, 2022
Josh Gottheimer House · D-NJ 5	Purchase$1,001 - $15,000 · Joint	Sep 20, 2021	Aug 20, 2021	Filing for HALO on Aug 20, 2021
Gilbert Ray Cisneros, Jr. House · D-CA 39	Purchase$1,001 - $15,000	Nov 5, 2020	Oct 22, 2020	Filing for HALO on Oct 22, 2020
Josh Gottheimer House · D-NJ 5	Purchase$1,001 - $15,000 · Joint	Nov 5, 2020	Oct 19, 2020	Filing for HALO on Oct 19, 2020

When several House members traded Halozyme Therapeutics, Inc.

Months when 2 or more House members became net buyers, or 3 or more net sellers, of Halozyme Therapeutics, Inc. in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. Only House members' electronic trade reports are included; Senate reports and reports filed on paper are not. After the 1 buying crowd with six months of prices, it averaged −16.7% against the index. One company's history is too short to judge by; the test across every company is the better guide.

Month	Crowd	3 months on, vs S&P 500	6 months	12 months
November 30, 2020	2 buying	+1.4%	−16.7%	−43.5%

Colours show whether the crowd was right: green when buyers were followed by a rise above the index, or sellers by a fall below it. Total returns from the month end; past patterns are not a forecast.

Source: periodic transaction reports filed with the Clerk of the House of Representatives under the STOCK Act (Senate reports are not included yet). Members report trades by themselves, their spouses and dependent children. Amounts are the value ranges as filed, not exact figures, and a report can be filed up to 45 days after the trade, so the latest trades may not appear yet. Scanned paper reports are linked but not transcribed. By law (5 U.S.C. §13107) these reports may not be used for any commercial purpose other than by news and communications media for dissemination to the general public; we publish them free, as news.

← Back to Halozyme Therapeutics, Inc. · Insider trading · Funds · All trades by members of Congress